Daniel Kelly

Dr. Daniel Kelly is a Senior Lecturer at the School of Biosciences and Chemistry, University of Sheffield Hallam, within the College of Health, Wellbeing and Life Sciences. He holds affiliations with the Biomolecular Sciences Research Centre and Health Research Institute. His research focuses on testosterone's role in cardiovascular disease, type-2 diabetes, and obesity, with emphasis on metabolic actions and tissue-specific effects. He has collaborated with institutions like the University of Sheffield, University of Chile, Barnsley NHS Trust, and Bayer Healthcare. His work has been featured on BBC News Health and earned the Kroto Research Inspiration Award (2016).

Teaching: Dr. Kelly specializes in biochemistry, metabolism, immunology, and disease mechanisms, and serves as deputy course leader for the Biomedical Sciences undergraduate program. He is a Fellow of the Higher Education Academy.

Research highlights include developing a 3D in vitro artery model for diabetic atherosclerosis and investigating testosterone's protective effects against cardiovascular risk. His studies are supported by grants from the Society for Endocrinology and published in top journals like *Nature Reviews Endocrinology* and *Journal of Endocrinology*. He has supervised doctoral students, including Lauren Bateman (anti-inflammatory effects of testosterone on atherosclerosis) and Robert Tempest (extracellular vesicles in adipose cells).

Professional activities include peer-review roles, external examining at the University of Sheffield, and an honorary lectureship at the University of Sheffield (2016).